VK-1727

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

VK-1727 is a selective small molecule inhibitor of EBNA1. VK-1727 can reduce EBNA1 DNA binding activity. VK-1727 selectively blocks the proliferation and metabolic activity of EBV+ cells, instead of EBV- cells. VK-1727 is used in multiple sclerosis research.

For research use only. We do not sell to patients.

  • Purity: 99.88%
  • Formula: C29H25NO4
  • Molecular Weight:451.51
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) VK-1727

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00